InspireMD Price To Sales vs. Cash And Equivalents
| NSPR Stock | USD 3.00 0.02 0.67% |
InspireMD Price To Sales Ratio |
|
For InspireMD profitability analysis, we use financial ratios and fundamental drivers that measure the ability of InspireMD to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well InspireMD utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between InspireMD's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of InspireMD over time as well as its relative position and ranking within its peers.
InspireMD |
InspireMD's Revenue Breakdown by Earning Segment
Check out Correlation Analysis.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.71) | Revenue Per Share 0.18 | Quarterly Revenue Growth 0.163 | Return On Assets (0.37) | Return On Equity (0.67) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
InspireMD Cash And Equivalents vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining InspireMD's current stock value. Our valuation model uses many indicators to compare InspireMD value to that of its competitors to determine the firm's financial worth. InspireMD is rated below average in price to sales category among its peers. It is regarded fifth in cash and equivalents category among its peers creating about 2,307,337 of Cash And Equivalents per Price To Sales. At this time, InspireMD's Price To Sales Ratio is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value InspireMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.InspireMD Cash And Equivalents vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
InspireMD |
| = | 11.47 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
InspireMD |
| = | 26.47 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
InspireMD Cash And Equivalents Comparison
InspireMD is currently under evaluation in cash and equivalents category among its peers.
InspireMD Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in InspireMD, profitability is also one of the essential criteria for including it into their portfolios because, without profit, InspireMD will eventually generate negative long term returns. The profitability progress is the general direction of InspireMD's change in net profit over the period of time. It can combine multiple indicators of InspireMD, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.4 M | -1.3 M | |
| Operating Income | -21.1 M | -20.1 M | |
| Income Before Tax | -19.9 M | -20.8 M | |
| Net Loss | -19.9 M | -20.9 M | |
| Income Tax Expense | 65 K | 68.2 K | |
| Total Other Income Expense Net | 1.3 M | 1.4 M | |
| Net Loss | -19.9 M | -20.9 M | |
| Net Loss | -21.3 M | -22.3 M | |
| Non Operating Income Net Other | -184 K | -193.2 K | |
| Interest Income | 1.3 M | 752 K | |
| Net Interest Income | 1.3 M | 1.4 M | |
| Change To Netincome | 2.1 M | 2.4 M | |
| Net Loss | (0.82) | (0.86) | |
| Income Quality | 0.82 | 0.59 | |
| Net Income Per E B T | 1.00 | 0.80 |
InspireMD Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on InspireMD. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of InspireMD position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the InspireMD's important profitability drivers and their relationship over time.
Use InspireMD in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.InspireMD Pair Trading
InspireMD Pair Trading Analysis
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your InspireMD position
In addition to having InspireMD in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Disruptive Technologies Thematic Idea Now
Disruptive Technologies
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 64 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.